2nd International Conference on Immunity and Immunochemistry

Aug 09-10, 2021


Barcelona, Spain

Welcome Message
“As we all know the Coronavirus disease 2019 (COVID-19) pandemic, brought about by extreme intense respiratory disorder Coronavirus 2 (SARS-CoV-2) has influenced a huge number of individuals around the world, touching off an unprecedented effort from mainstream researchers to comprehend the organic supporting of COVID19 pathophysiology. The immune system ensures against infections and sicknesses and produces antibodies to kill microbes.”
We’re delighted to welcome you to the 2nd International Conference on Immunity and Immunochemistry, taking place on August 09-10, 2021 in Barcelona, Spain. This event takes place over 2 days and will comprise plenary lectures, parallel sessions, poster sessions and our ever-popular ‘Workshop’ events, with something to suit all immunological and vaccines research. 
 About the Conference
Immunochemistry 2021 gives a profound impulse into the most recent discoveries and innovative headway in the field of Immunity and Immunochemistry. With individuals from around the globe focused in on finding out about Immunology and its advances; this is your best opportunity to arrive at the biggest array of members from the Immunology community. Widely acclaimed speakers, the latest   strategies, advancements, and the most up to date refreshes in Immunology are signs of this gathering.
The aim of the event is to host shows from far-famed specialists across the planet to harness the new collaborations in medical specialty, and medical specialty Sciences. Therefore, researchers within the relevant field will gift their analysis to debate the new results. rising sessions includes, young researchers forum and poster sessions providing likelihood to young participants to develop their career. Through the oral and poster displays, scientific sessions, and networking sessions, we tend to encourage dialogue between all the attendees to fill within the gaps to inspire innovative collaborations. 

Target Audience

  • Immunologists, Virologists, Microbiologists
  • Allergists, Pathologists, Biotechnologists
  • Physicians and Infectious diseases treatment doctors
  • University Professors
  • Research Labs
  • Various Societies Members
  • Research Scholars and Medical Students
  • Business Entrepreneurs
  • Manufacturing Medical Devices and Pharma Companies
  • Laboratory Technicians

Why to attend?

The attendees will notice exclusive sessions and panel discussions on the most recent innovations in Molecular medical specialty & Immunogenetics, be the first to showcase your analysis, innovation.

  • Lectures from noted speakers
  • Keynote forums by outstanding Professors and Directors
  • Open Innovation Challenges
  • Certification
  • Poster displays by Young Researchers
  • Global Networking sessions with 50+ Countries
  • Strengthening the network between the university, hospitals, research labs and pharma industries.
  • Summarize the studies of Immune System and targeting therapies to prevent coronavirus disease.
  • Discussing the latest findings and achievements in the treatment of Covid-19 through immunotherapies.

Market Scenario

Global Immune Health Supplements Market was valued at US$ 14.1 Bn in 2019 and is expected to reach US$ 24.7 Bn by 2027, at a CAGR of 7.26% during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market; same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The global immune health supplements market is driven by the increased awareness regarding the benefits of the immune health supplements among consumers. Increasing consumption of immune health supplements around the globe, which is anticipated to drive the immune health supplements market growth in the forecast period. The rise in chronic diseases around the globe, which is influencing the demand for immune health supplements. In addition, rising demand for the immune health supplements coupled with changing lifestyles of consumers across global, which is also estimated to fuel the global immune health supplements market growth in a positive way. Increased investments in R&D are driving the global immune health supplements market growth in a positive way. However, lack of awareness regarding immune health supplements among consumers is expected to hamper the global immune health supplements market growth in the forecast period.

COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025

The global COVID-19 vaccines market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period. The growth of the COVID vaccines market is attributed majorly to the rising number of people infected with COVID-19 and increasing funding for vaccine development.

On the other hand, the global COVID-19 drugs market is projected to reach USD 2 million by 2025 from USD 165 million in 2020, at a CAGR of -57.8% during the forecast period. The growth of the COVID drugs market is primarily attributed to use of repurposed drugs for compassionate use, and the emergence of alternative therapies such as convalescent plasma therapy which were earlier used for treating epidemic diseases such as SARS, MERS, and H1N1. Moreover, collaborations between global organizations and governments of various nations to promote the supply of essential drugs and medical supplies are fueling the market growth.

Currently, the R&D landscape for COVID-19 vaccines includes 115 vaccine candidates. The most advanced candidates that have recently moved into clinical development are:

  • mRNA-1273 from Moderna
  • Ad5-nCoV from CanSino Biologics
  • INO-4800 from Inovio
  • LV-SMENP-DC and pathogen-specific aAPC from Shenzhen Geno-Immune Medical Institute

Vaccine manufacturing ramp-up to drive the growth further

Currently, around 155 molecules are under clinical investigation, and about 45 molecules are under preclinical development to be targeted against COVID-19. In this list, four promising drugs have been repurposed for use against COVID-19.

Chloroquine and hydroxychloroquine
Lopinavir and ritonavir (and that same combination plus interferon-beta)
An immune system messenger that can help stop the multiplication of viruses.

K M Yacob
Chief Physician
Marma Health Centre, India


K. M. Yacob is a practicing physician in the field of healthcare in the state of Kerala in India for the last 31years and very much interested in basic research. His interest is spread across the fever, inflammation and back pain. He is a writer and already printed and published nine books on these subjects. He wrote hundreds of articles in various magazines. After scientific studies, he has developed 8000 affirmative cross checking questions. It  can explain all queries related to fever.

Researches :

  • fever, inflammation and back pain
Carol Apt
South Carolina State University, USA


Carol Apt has received her PhD in Sociology from Northeastern University in Boston, Massachusetts, her Master's Degree in Sociology from Boston University in Boston, Massachusetts, and her Bachelor's Degree in Sociology from Indiana University in Indianapolis, Indiana. She also has a certificate of French Studies from Ecole Lemania in Lausanne, Switzerland. She is a Professor of Sociology and the Coordinator of the Sociology Program at South Carolina State University in Orangeburg, South Carolina, where she has been for 20 years. She teaches courses in Human Sexuality, Medical Sociology, Social problems, and the Sociology of Genocide. In 2011, she was honored as the South Carolina State University Professor of the Year. She is a Member of several Editorial Boards and is a Consulting Member of the South Carolina Medical Association Bioethics Committee. In addition to her experience as an author and newspaper and magazine columnist, she is the host of a live, call-in talk radio show entitled, "Talk to Me," which addresses issues of sexuality and relationships. It is broadcast on 90.3 FM, WSSB, an NPR affiliate.

Researches :

  • Human Sexuality, Medical Sociology, and Social problems
El Hadji Seydou Mbaye
International Agency for Research on Cancer, France


Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France).

Researches :

  • Virology and Biochemistry
Huang Wei Ling
Medical Nutrition Therapist
Medical Acupuncture and Pain Management Clinic


Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Researcher in the University of São Paulo, in the Ophthalmology department from 2012 to 2013.

Researches :

  • chronic diseases and Infection control
John Miles
Principal Research Fellow
Institute of Tropical Health and Medicine
James Cook University


Professor John Miles is Principal Research Fellow of Molecular Immunology at the Australian Institute of Tropical Health and Medicine, James Cook University, Australia. He is co-director for the Centre for Tropical Bioinformatics and Molecular Biology and theme leader for the Centre for Molecular Therapeutics at James Cook University. Professor Miles is an expert in human immune system monitoring and modulation, where he has published 117 papers (h-index 44 and 6,700 citations), I am in the 100th percentile in percentile by my worldwide Topic of Cluster Prominence in my field of T cell biology.

Researches :

  • Molecular Biology and Molecular Therapeutics

Program Overview

Our Collaborations, Sponsors, Media Partners